Company Filing History:
Years Active: 1989-1993
Title: Paul H Andersson: Innovator in Pharmaceutical Compounds
Introduction
Paul H Andersson is a prominent inventor located in Södra Sandby, Sweden, recognized for his contributions to the field of pharmaceuticals. With a total of three patents to his name, he has made significant advancements in developing compounds with promising therapeutic effects. His work primarily focuses on addressing inflammatory, allergic, and dermatological conditions, showcasing his commitment to improving health outcomes.
Latest Patents
Among his latest patents, Paul H Andersson has developed innovative compounds including "16,17-acetalsubstituted pregnane 21-oic acid derivatives." This invention refers to compounds that exhibit activity against a variety of inflammatory and allergic conditions. These compounds are characterized by the formula ##STR1## or a stereoisomeric component thereof, where R.sub.1 is selected from a straight or branched hydrocarbon chain having 1-4 carbon atoms. Additionally, he has created processes for the preparation of these compounds, which can be utilized in pharmaceutical preparations aimed at treating musculoskeletal and dermatological conditions.
Another significant patent is the "16,17-acetalsubstituted androstane-17.beta.-carboxylic acid esters," which has demonstrated anti-inflammatory activity. This invention is also characterized by a specific formula ##STR1## or a stereoisomer component thereof, where the 1,2-position is either saturated or contains a double bond. These compounds hold potential for advancing the treatment of various inflammatory conditions.
Career Highlights
Paul H Andersson is currently associated with Aktiebolaget Draco, a company dedicated to the formulation of pharmaceutical products that aim to meet significant medical needs. His dedication to innovation in chemistry and pharmacology has set him apart as a leading figure in his field.
Collaborations
Throughout his career, Paul has collaborated with notable colleagues such as Per T Andersson and Bengt I Axelsson. These collaborations have fostered a rich environment for sharing ideas and furthering research initiatives that contribute to the development of effective pharmaceutical solutions.
Conclusion
In conclusion, Paul H Andersson's work in developing compounds for treating inflammatory and allergic conditions highlights his valuable contributions to pharmaceutical science. His innovative mindset and focus on therapeutic efficacy demonstrate the importance of continuous research and development in creating effective treatments for a range of health issues.